accesso Technology (ACSO LN) Positive first half, full year expected to be in line | Cello Health (CLL LN) Health driving performance | Eckoh (ECK LN) A good start to the year | EKF Diagnostics (EKF LN) Interims slightly ahead, outlook positive | Elektron Technology (EKT LN) H1 19 in line with recently upgraded forecasts | Ergomed (ERGO LN) H1 results: in line with June trading update | Futura Medical (FUM LN) Business update highlights increased focus on MED2002 | ReNeuron Group (RENE LN) Excl ....
19 Sep 2018
Morning Song
accesso Technology Group Plc (ACSO:LON), 534 | Cello Health (CLL:LON), 0 | Eckoh plc (ECK:LON), 38.0 | EKF Diagnostics Holdings plc (EKF:LON), 27.8 | Checkit plc (CKT:LON), 21.0 | Futura Medical plc (FUM:LON), 40.1 | ReNeuron Group plc (RENE:LON), 0 | Yu Group PLC (YU:LON), 1,800
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Song
accesso Technology Group Plc (ACSO:LON), 534 | Cello Health (CLL:LON), 0 | Eckoh plc (ECK:LON), 38.0 | EKF Diagnostics Holdings plc (EKF:LON), 27.8 | Checkit plc (CKT:LON), 21.0 | Futura Medical plc (FUM:LON), 40.1 | ReNeuron Group plc (RENE:LON), 0 | Yu Group PLC (YU:LON), 1,800
- Published:
19 Sep 2018 -
Author:
N+1 Singer Team -
Pages:
18
accesso Technology (ACSO LN) Positive first half, full year expected to be in line | Cello Health (CLL LN) Health driving performance | Eckoh (ECK LN) A good start to the year | EKF Diagnostics (EKF LN) Interims slightly ahead, outlook positive | Elektron Technology (EKT LN) H1 19 in line with recently upgraded forecasts | Ergomed (ERGO LN) H1 results: in line with June trading update | Futura Medical (FUM LN) Business update highlights increased focus on MED2002 | ReNeuron Group (RENE LN) Excl ....